In the present studies these findings have been extended and we have examined the effect of neuroleptic drugs of various structures on the dopamine-sensitive adenylate cyclase of the rat corpus striatum to obtain information on their potencies as inhibitors of this system. Table 1 . Inhibition of dopamine-sensitive adenylate cyclase activity in rat,corpus striatum by drugs
Recent findings indicate that the neurotransmitter functions of catecholamines in the central nervous system may be mediated by cyclic AMP. Hoffer et al. (1972) demonstrated the involvement of cyclic AMP in the hyperpolarization of cerebellar Purkinje neurons by noradrenaline. A similar role for cyclic AMP in mediating the actions of dopamine(3,4-dihydroxyphenethylamine) is suggested by the observations that low concentrations increase cyclic AMP production in homogenates of central nervous system areas that contain dopamine neurons such as the retina (Brown & Makman, 1972) and corpus striatum (Kebabian et al., 1972 ) of rat brain. The results suggest that the dopamine-sensitive adenylate cyclase may represent a model for studies of dopamine receptors in brain. There is much indirect neuropharmacological evidence suggesting that the antipsychotic effects of neuroleptic drugs result from their blockade of central dopamine receptors (see Matthysse, 1973 In the present studies these findings have been extended and we have examined the effect of neuroleptic drugs of various structures on the dopamine-sensitive adenylate cyclase of the rat corpus striatum to obtain information on their potencies as inhibitors of this system. Table 1 . Inhibition of dopamine-sensitive adenylate cyclase activity in rat,corpus striatum by drugs ICs0 is the drug concentration required to produce 50% inhibition of adenylate cyclase activity evoked by 100pM-dopamine, these values are determined graphically as in The method used was similar to that described by Kebabian et al. (1972) . Male albino Wistar rats (180-25Og) were decapitated and their brains removed in a cold room (4°C). The striata were dissected and homogenized in 25vol. of cold 2mM-Trismaleate buffer, pH 7.4, containing ~~M -E G T A [ethanedioxybis(ethylamine)tetra-acetic acid]. Portions (50~1) of the homogenates were incubated with 2 5 0~1 of 80m~-Tris-maleate buffer, pH7.4, containing 0.2m-EGTA, IOmM-theophylline and 2.0m~-MgSO,. Homogenates of corpus striatum were incubated with and without 100pM-dopamine and various concentrations of test drugs. The basal amount of cyclic AMP production in the absence of added dopamine was 46.5f2.43pmol of cyclic AMP per incubation (mean f S.E.M. for 14 experiments) and this rose to 93.6f3.36 pmol of cyclic AMP in the presence of dopamine. % inhibition by drugs is defined as the percentage inhibition of the dopamine-stimulated portion of the adenylate cyclase activity; in some cases inhibition exceeded 100% because at high concentrations drugs inhibited part of the basal activity. Each point is the mean of 6 1 2 determinations, S.E.M. values were less than *lo%.
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The adenylate cyclase reaction was initiated by addition of ATP (5pl) to give a final concentration of 0 . 5 m~. Tubes were incubated with shaking for 2.5min at 30°C and thereaction was stopped by placing the tubes in a boiling water bath for 3 min. Insoluble material was removed by centrifugation and 2 0 4 of the supernatant was analysed for cyclic AMP by the method of Brown et al. (1972) . Dopamine produced a maximal stimulation of approximately 100% over the basal amounts of cyclic AMP production in control incubations. Half-maximal stimulation was obtained with approximately Sp~-dopamine, and maximal stimulation with 30 p-dopamine. The dopamine-mimetic drug apomorphine also stimulated cyclic AMP production, but was considerably less potent than dopamine.
The effects of adding psychoactive drugs of various structures to the incubation were examined (Table 1 ; Fig. 1) . With a stimulating concentration of lOOpM-dopamine, chlorpromazine produced a 50 % blockade of the rise in cyclic AMP production at a concentration of 1 p~. Pharmacologically active metabolites of chlorpromazine such as the desmethyl metabolite were also effective as inhibitors in this system. Pharmacologically inert metabolites of chlorpromazine such as the sulphoxide were without inhibitory activity at concentrationsupto0.1 mM. Phenothiazines withno, or only weak, neuroleptic activity also showed decreased blocking activity; these included promazine and the antihistamine promethezine. The tricyclic antidepressant chlorimipramine was also only weakly active. Other phenothiazines with neuroleptic activity, such as prochlorperazine and thioridazine, were potent blockers of the effect of dopamine. Drugs containing the -CF3 group in place of the -Cl group such as fluphenazine, which are clinically the most potent phenothiazines, were also the most powerful blockers. Fluphenazine caused a 50% blockade at a concentration of less than 0.1 WM, as did its thioxanthene analogue flupenthixol. Neuroleptic drugs of other structures were also effective blockers, although this did not correlate well with their potencies in vivo. Thus spiroperidol and pimozide are among the most potent neuroleptics known, but their blocking activities were in the concentration range of chlorpromazine rather than fluphenazine. The anti-Parkinsonian drug benztropine is a very potent inhibitor of the uptake of dopamine into synaptosomes (Coyle & Snyder, 1969) . However, this drug was ineffective in inhibiting the effect of dopamine in this system, suggesting that uptake sites and receptors for dopamine recognize different features of the molecule. In addition the relative ineffectiveness of morphine in blocking the effect of dopamine suggests that the receptors for morphine and other opiate drugs are not the same as those for dopamine (Pert & Snyder, 1973) . Prostaglandin El, which has been shown to affect adenylate cyclase activity in several systems, was ineffective at concentrations up to O.lmM either in stimulating cyclic AMP production or in blocking the effects of dopamine.
In summary, neuroleptic drugs of various structures were more effective in blocking the rise in cyclic AMP production elicited by dopamine than non-neuroleptic drugs with closely related structures. The potencies of the phenothiazines in this system correlate well with their clinical potencies, but this is not so with other neuroleptics.
However, this may be explained by other factors operating in vivo. Thus the high potencies of spiroperidol and pimozide seen in vivo may be due to either the formation of active metabolites or to a more specific localization of these substances in the central nervous system. There is some evidence for the latter proposal; thus, whereas chlorpromazine was evenly distributed in the rat brain after injection, pimozide showed a selective accumulation in the caudate nucleus (Soudijn & van Wijngaarden, 1972) .
A chlorpromazine-sensitive dopamine-stimulated adenylate cyclase also occurs in two other dopamine-rich areas of the rat brain, the nucleus accumbens and the olfactory tubercle (Horn et al., 1973) . The actions of neuroleptics on these systems will be of interest.
